These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18349521)

  • 1. Nonsteroidal anti-inflammatory drugs and ectodomain shedding of the amyloid precursor protein.
    Leuchtenberger S; Maler J; Czirr E; Ness J; Lichtenthaler SF; Esselmann H; Pietrzik CU; Wiltfang J; Weggen S
    Neurodegener Dis; 2009; 6(1-2):1-8. PubMed ID: 18349521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective neurite extension is caused by a mutation in amyloid beta/A4 (A beta) protein precursor found in familial Alzheimer's disease.
    Li HL; Roch JM; Sundsmo M; Otero D; Sisodia S; Thomas R; Saitoh T
    J Neurobiol; 1997 May; 32(5):469-80. PubMed ID: 9110259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibuprofen decreases cytokine-induced amyloid beta production in neuronal cells.
    Blasko I; Apochal A; Boeck G; Hartmann T; Grubeck-Loebenstein B; Ransmayr G
    Neurobiol Dis; 2001 Dec; 8(6):1094-101. PubMed ID: 11741404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-steroidal anti-inflammatory drugs stimulate secretion of non-amyloidogenic precursor protein.
    Avramovich Y; Amit T; Youdim MB
    J Biol Chem; 2002 Aug; 277(35):31466-73. PubMed ID: 12070143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrine alters the secretion of the beta-amyloid precursor protein in cell lines.
    Lahiri DK; Lewis S; Farlow MR
    J Neurosci Res; 1994 Apr; 37(6):777-87. PubMed ID: 8046778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action.
    Gasparini L; Ongini E; Wenk G
    J Neurochem; 2004 Nov; 91(3):521-36. PubMed ID: 15485484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease.
    Reznichenko L; Amit T; Zheng H; Avramovich-Tirosh Y; Youdim MB; Weinreb O; Mandel S
    J Neurochem; 2006 Apr; 97(2):527-36. PubMed ID: 16539659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of amyloid precursor protein reduces epsilon protein kinase C levels.
    Liron T; Seraya CB; Ish-Shalom M; Souroujon MC; Neumann D
    Neuroscience; 2007 Apr; 146(1):152-9. PubMed ID: 17321053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretion kinetics of Alzheimer's amyloid beta-protein differs from secreted beta-amyloid precursor protein.
    Araki W; Kunishita T; Takahashi K; Ikeda S; Tabira T
    Biochem Biophys Res Commun; 1995 Sep; 214(2):490-5. PubMed ID: 7677756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mefenamic acid shows neuroprotective effects and improves cognitive impairment in in vitro and in vivo Alzheimer's disease models.
    Joo Y; Kim HS; Woo RS; Park CH; Shin KY; Lee JP; Chang KA; Kim S; Suh YH
    Mol Pharmacol; 2006 Jan; 69(1):76-84. PubMed ID: 16223958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S- but not R-enantiomers of flurbiprofen and ibuprofen reduce human microglial and THP-1 cell neurotoxicity.
    Klegeris A; Maguire J; McGeer PL
    J Neuroimmunol; 2004 Jul; 152(1-2):73-7. PubMed ID: 15223239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity requires soluble amyloid precursor protein alpha to promote neurite outgrowth in neural stem cell-derived neurons via activation of the MAPK pathway.
    Gakhar-Koppole N; Hundeshagen P; Mandl C; Weyer SW; Allinquant B; Müller U; Ciccolini F
    Eur J Neurosci; 2008 Sep; 28(5):871-82. PubMed ID: 18717733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin alters the metabolism of the beta-amyloid precursor protein in the neuroendocrine cell line PC12.
    Song W; Lahiri DK
    J Mol Neurosci; 1997 Oct; 9(2):75-92. PubMed ID: 9407389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polarized transport of Alzheimer amyloid precursor protein is mediated by adaptor protein complex AP1-1B.
    Icking A; Amaddii M; Ruonala M; Höning S; Tikkanen R
    Traffic; 2007 Mar; 8(3):285-96. PubMed ID: 17319802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of APP stimulates basal and constitutive exocytosis in PC12 cells.
    Lee HW; Park JW; Sandagsuren EU; Kim KB; Yoo JJ; Chung SH
    Neurosci Lett; 2008 May; 436(2):245-9. PubMed ID: 18395981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sulindac sulfide on the membrane architecture and the activity of gamma-secretase.
    Gamerdinger M; Clement AB; Behl C
    Neuropharmacology; 2008 May; 54(6):998-1005. PubMed ID: 18359496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular sAPP retention in response to Abeta is mapped to cytoskeleton-associated structures.
    Henriques AG; Vieira SI; Crespo-López ME; Guiomar de Oliveira MA; da Cruz e Silva EF; da Cruz e Silva OA
    J Neurosci Res; 2009 May; 87(6):1449-61. PubMed ID: 19105196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the neurotrophic interaction between nerve growth factor and secreted alpha-amyloid precursor protein.
    Luo JJ; Wallace MS; Hawver DB; Kusiak JW; Wallace WC
    J Neurosci Res; 2001 Mar; 63(5):410-20. PubMed ID: 11223916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble form of amyloid precursor protein regulates proliferation of progenitors in the adult subventricular zone.
    Caillé I; Allinquant B; Dupont E; Bouillot C; Langer A; Müller U; Prochiantz A
    Development; 2004 May; 131(9):2173-81. PubMed ID: 15073156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of beta-amyloid precursor protein secretion in differentiated and nondifferentiated cells.
    Löffler J; Huber G
    Biochem Biophys Res Commun; 1993 Aug; 195(1):97-103. PubMed ID: 8395841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.